Efficacy and Safety Study of Inhaled Glutathione in Cystic Fibrosis Patients
NCT00506688
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
153
Enrollment
OTHER
Sponsor class
Conditions
Cystic Fibrosis
Interventions
DRUG:
reduced glutathione sodium salt
DRUG:
0.9% normal saline (control)
Sponsor
Mukoviszidose Institut gGmbH
Collaborators
[object Object]